Hauser, S., Bar-Or, A., Cohen, J., Comi, G., Correale, J., Coyle, P., … Trial, G. A. I. and A. , II. (2020). Ofatumumab versus Teriflunomide in Multiple Sclerosis. The New England Journal of Medicine, 383(6), 546-557. https://doi.org/10.1056/NEJMoa1917246 (Original work published 2020)
Groups. Trial II
First name:
Groups.
Middle name:
ASCLEPIOS I and ASCLEPIOS
Last name:
Trial
Suffix:
II